ASSOCIATION OF KI-RAS MUTATION WITH DIFFERENTIATION AND TUMOR-FORMATION PATHWAYS IN COLORECTAL-CARCINOMA

被引:64
作者
LAURENTPUIG, P
OLSCHWANG, S
DELATTRE, O
VALIDIRE, P
MELOT, T
MOSSERI, V
SALMON, RJ
THOMAS, G
机构
[1] INST CURIE,BIOL SECT,26 RUE ULM,F-75231 PARIS 05,FRANCE
[2] INST CURIE,MED SECT,F-75231 PARIS 05,FRANCE
关键词
D O I
10.1002/ijc.2910490213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence of a point mutation on the 12th and 13th codons of the Ki-ras oncogene has been investigated in 99 colorectal carcinomas in relation to 3 histological parameters: extent of differentiation, occurrence of a mucinous component within the tumor, and presence of peripheral adenomatous polyp remnants. The mutation frequency increased with each parameter: from 13% (2/15) to 44% (37/84) with differentiation, from 33% (26/79) to 65% (13/20) with mucinous character, and from 27% (15/56) to 56% (24/43) with the presence of polyp remnants. The frequency was highest in well-differentiated mucinous tumors with adenomatous remnants 83% (5/6). We suggest that Ki-ras mutation is preferentially involved in carcinomas that have developed from adenoma and that the mutation preserves differentiation and mucin secretion in these cancer cells.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 45 条
[1]   THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM [J].
ASTLER, VB ;
COLLER, FA .
ANNALS OF SURGERY, 1954, 139 (06) :846-852
[2]  
AUGENLICHT LH, 1987, CANCER RES, V47, P3763
[3]  
BAGLI DJ, 1990, CANCER RES, V50, P2518
[4]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[5]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[6]   C-KI-RAS MUTATIONS IN CHRONIC ULCERATIVE-COLITIS AND SPORADIC COLON-CARCINOMA [J].
BURMER, GC ;
LEVINE, DS ;
KULANDER, BG ;
HAGGITT, RC ;
RUBIN, CE ;
RABINOVITCH, PS .
GASTROENTEROLOGY, 1990, 99 (02) :416-420
[7]  
CRAWFORD BE, 1983, CANCER, V51, P1760, DOI 10.1002/1097-0142(19830501)51:9<1760::AID-CNCR2820510933>3.0.CO
[8]  
2-N
[9]  
DELATTRE O, 1989, LANCET, V2, P353
[10]  
FARR CJ, 1988, ONCOGENE, V3, P673